Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Precursor Cell Lymphoblastic Leukemia-lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Study completedNCT02435849
What this trial is testing

Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Novartis Pharmaceuticals 80
Not applicableUnknownNCT05059847
What this trial is testing

Impact of Cross-training on Induction Treatment Response in Acute Lymphoblastic Leukemia Adults

Who this might be right for
Acute Lymphoblastic Leukemia, Adult B-Cell
Hospital General de Mexico 114
Not applicableStudy completedNCT05386355
What this trial is testing

Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool

Who this might be right for
COVID-19 VaccinesTelemedicineVaccine Hesitancy+1 more
IDeA States Pediatric Clinical Trials Network 1,934
Not applicableUnknownNCT05729178
What this trial is testing

Unravelling the Role of KCTD Protein Family in the Clinical Management of Childhood Acute Lymphoblastic Leukemias

Who this might be right for
Childhood Acute Lymphoblastic Leukemia
IRCCS SYNLAB SDN 80
Testing effectiveness (Phase 2)Looking for participantsNCT07008885
What this trial is testing

BCOR and ZC3H12 Genes Knock-out CD19-targeting CAR-T Cell Therapy in r/r B-ALL

Who this might be right for
Acute Lymphocytic Leukemia
Chinese PLA General Hospital 30
Early research (Phase 1)Study completedNCT00040950
What this trial is testing

Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Looking for participantsNCT03081910
What this trial is testing

Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen

Who this might be right for
T-cell Acute Lymphoblastic LymphomaT-non-Hodgkin LymphomaT-cell Acute Lymphoblastic Leukemia
Baylor College of Medicine 54
Early research (Phase 1)UnknownNCT04289220
What this trial is testing

Anti-CD19 CAR in PiggyBac Transposon-Engineered T Cells for Relapsed/Refractory B-cell Lymphoma or B-cell Acute Lymphoblastic Leukemia

Who this might be right for
B Cell LymphomaB-cell Acute Lymphoblastic Leukemia
Yan'an Affiliated Hospital of Kunming Medical University 10
Large-scale testing (Phase 3)UnknownNCT02451774
What this trial is testing

Pentoxifylline In Pediatric Acute Lymphoblastic Leukemia During Induction

Who this might be right for
Acute Lymphoblastic Leukemia
Ramón Óscar González-Ramella, Ph.D 44
Post-approval studies (Phase 4)Study completedNCT00199004
What this trial is testing

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

Who this might be right for
Adult Acute Lymphocytic Leukemia
Johann Wolfgang Goethe University Hospital 60
Not applicableLooking for participantsNCT05809284
What this trial is testing

Determining the Mechanisms of Loss of CAR T Cell Persistence

Who this might be right for
Acute Lymphoblastic Leukemia With Failed RemissionAcute Lymphoblastic Leukemia Not Having Achieved RemissionAcute Lymphoblastic Leukemia, Pediatric+2 more
University College, London 50
Testing effectiveness (Phase 2)UnknownNCT03265106
What this trial is testing

A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma Subjects

Who this might be right for
Relapsed B-cell Acute Lymphoblastic Leukemia, ChildhoodRefractory B-cell Acute Lymphoblastic Leukemia, ChildhoodRelapsed/Refractory B-cell Lymphoma, Childhood
Shenzhen BinDeBio Ltd. 20
Large-scale testing (Phase 3)UnknownNCT03564704
What this trial is testing

Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

Who this might be right for
LeukemiaLeukemia, AcuteAdult Lymphoblastic Lymphoma+5 more
Nanfang Hospital, Southern Medical University 80
Very early researchLooking for participantsNCT07695012
What this trial is testing

CAR-T Cell Therapy for ALL

Who this might be right for
Relapsed Acute Lymphoblastic Leukemia (ALL)
Dr. Zaineb Akram 10
Not applicableNot Yet RecruitingNCT06746571
What this trial is testing

Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients

Who this might be right for
Lymphoblastic Leukemia
Sohag University 100
Not applicableLooking for participantsNCT06600568
What this trial is testing

Novel Therapeutic Approach for Human T-cell Malignancies

Who this might be right for
T-Cell Leukemia/Lymphoma, Adult
Istituto Oncologico Veneto IRCCS 120
Not applicableUnknownNCT00402090
What this trial is testing

DHPLC Determination of TPMT Polymorphisms.

Who this might be right for
Acute Lymphoblastic Leukemia
National Institute of Cancerología 160
Testing effectiveness (Phase 2)Ended earlyNCT05086315
What this trial is testing

First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Who this might be right for
Acute Lymphocytic LeukaemiaAcute Myeloid Leukaemia RefractoryMyelodysplastic Syndromes+1 more
Sanofi 101
Testing effectiveness (Phase 2)Study completedNCT00702403
What this trial is testing

Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionBlastic Phase Chronic Myelogenous Leukemia+11 more
Fred Hutchinson Cancer Center 40
Next Page